Therapeutics on Tenu Tech Brief https://cluster-site.onrender.com/tags/therapeutics/ Recent content in Therapeutics on Tenu Tech Brief Hugo -- 0.146.0 en-us Tue, 24 Feb 2026 06:03:20 +0000 Restoring the tumour mechanophenotype of vocal fold cancer reverts its malignant properties https://cluster-site.onrender.com/posts/restoring-the-tumour-mechanophenotype-of-vocal-fold-cancer-reverts-its-malignant-properties/ Sun, 22 Feb 2026 00:41:33 +0000 https://cluster-site.onrender.com/posts/restoring-the-tumour-mechanophenotype-of-vocal-fold-cancer-reverts-its-malignant-properties/ • ECM stiffness and deposition fuel vocal fold cancer progression through mechanotransduction. • Patient-derived cells show loss of laminin-binding integrins and flocking motility PTC Therapeutics Ends Bid to Seek FDA Approval for Rare Muscle Disease Drug https://cluster-site.onrender.com/posts/ptc-therapeutics-ends-bid-to-seek-fda-approval-for-rare-muscle-disease-drug/ Fri, 13 Feb 2026 19:26:09 +0000 https://cluster-site.onrender.com/posts/ptc-therapeutics-ends-bid-to-seek-fda-approval-for-rare-muscle-disease-drug/ • PTC Therapeutics said it cannot resolve differences it has with the FDA in interpreting clinical trial data for Translarna, a drug it developed for Duchenne muscular dystrophy. •